Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 2
2003 2
2005 2
2006 2
2007 5
2008 7
2009 4
2010 8
2011 5
2012 9
2013 9
2014 8
2015 9
2016 12
2017 11
2018 10
2019 18
2020 24
2021 10
2022 6
2023 14
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

161 results

Results by year

Filters applied: . Clear all
Page 1
Dosimetry for targeted radionuclide therapy in routine clinical practice: experts advice vs. clinical evidence.
Dieudonné A, Bailly C, Cachin F, Edet-Sanson A, Kraeber-Bodéré F, Hapdey S, Merlin C, Robin P, Salaun PY, Schwartz P, Tonnelet D, Vera P, Courbon F, Carlier T. Dieudonné A, et al. Among authors: kraeber bodere f. Eur J Nucl Med Mol Imaging. 2024 Mar;51(4):947-950. doi: 10.1007/s00259-023-06568-8. Eur J Nucl Med Mol Imaging. 2024. PMID: 38110711 Free PMC article. No abstract available.
Prognostic Value of 18F-FDG PET Radiomics Features at Baseline in PET-Guided Consolidation Strategy in Diffuse Large B-Cell Lymphoma: A Machine-Learning Analysis from the GAINED Study.
Carlier T, Frécon G, Mateus D, Rizkallah M, Kraeber-Bodéré F, Kanoun S, Blanc-Durand P, Itti E, Le Gouill S, Casasnovas RO, Bodet-Milin C, Bailly C. Carlier T, et al. Among authors: kraeber bodere f. J Nucl Med. 2024 Jan 2;65(1):156-162. doi: 10.2967/jnumed.123.265872. J Nucl Med. 2024. PMID: 37945379
How to attract young talent to nuclear medicine step 1: a survey conducted by the EANM Oncology and Theranostics Committee to understand the expectations of the next generation.
Ambrosini V, Carrilho Vaz S, Ahmadi Bidakhvidi N, Chanchou M, Cysouw MCF, Serani F, Voltin CA, Kraeber-Bodere F, Deroose CM, De Geus-Oei LF, Eiber M, Gnanasegaran G, Gotthardt M, Kobe C, Konijnenberg MW, Nanni C, Oprea Lager DE, Rahbar K, Taieb D, Mottaghy FM, Goffin K, Herrmann K. Ambrosini V, et al. Among authors: kraeber bodere f. Eur J Nucl Med Mol Imaging. 2023 Dec;51(1):3-11. doi: 10.1007/s00259-023-06389-9. Eur J Nucl Med Mol Imaging. 2023. PMID: 37689611 Free PMC article. No abstract available.
New Developments in Myeloma Treatment and Response Assessment.
Kraeber-Bodéré F, Jamet B, Bezzi D, Zamagni E, Moreau P, Nanni C. Kraeber-Bodéré F, et al. J Nucl Med. 2023 Sep;64(9):1331-1343. doi: 10.2967/jnumed.122.264972. Epub 2023 Aug 17. J Nucl Med. 2023. PMID: 37591548 Free PMC article.
European Association of Nuclear Medicine (EANM) Focus 4 consensus recommendations: molecular imaging and therapy in haematological tumours.
Nanni C, Kobe C, Baeßler B, Baues C, Boellaard R, Borchmann P, Buck A, Buvat I, Chapuy B, Cheson BD, Chrzan R, Cottereau AS, Dührsen U, Eikenes L, Hutchings M, Jurczak W, Kraeber-Bodéré F, Lopci E, Luminari S, MacLennan S, Mikhaeel NG, Nijland M, Rodríguez-Otero P, Treglia G, Withofs N, Zamagni E, Zinzani PL, Zijlstra JM, Herrmann K, Kunikowska J. Nanni C, et al. Among authors: kraeber bodere f. Lancet Haematol. 2023 May;10(5):e367-e381. doi: 10.1016/S2352-3026(23)00030-3. Lancet Haematol. 2023. PMID: 37142345 Free article. Review.
161 results